Histochemical approaches to assess cell-to-cell transmission of misfolded proteins in neurodegenerative diseases

G. Natale, E. Pompili, F. Biagioni, S. Paparelli, P. Lenzi, F. Fornai

Research output: Contribution to journalArticle

Abstract

Formation, aggregation and transmission of abnormal proteins are common features in neurodegenerative disorders including Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, and Huntington's disease. The mechanisms underlying protein alterations in neurodegenerative diseases remain controversial. Novel findings highlighted altered protein clearing systems as common biochemical pathways which generate protein misfolding, which in turn causes protein aggregation and protein spreading. In fact, proteinaceous aggregates are prone to cell-tocell propagation. This is reminiscent of what happens in prion disorders, where the prion protein misfolds thus forming aggregates which spread to neighbouring cells. For this reason, the term prionoids is currently used to emphasize how several misfolded proteins are transmitted in neurodegenerative diseases following this prion-like pattern. Histochemical techniques including the use of specific antibodies covering both light and electron microscopy offer a powerful tool to describe these phenomena and investigate specific molecular steps. These include: prion like protein alterations; glycation of prion-like altered proteins to form advanced glycation end-products (AGEs); mechanisms of extracellular secretion; interaction of AGEs with specific receptors placed on neighbouring cells (RAGEs). The present manuscript comments on these phenomena aimed to provide a consistent scenario of the available histochemical approaches to dissect each specific step.

Original languageEnglish
Pages (from-to)31-35
Number of pages5
JournalEuropean journal of histochemistry : EJH
Volume57
Issue number1
DOIs
Publication statusPublished - 2013

Fingerprint

Neurodegenerative Diseases
Prions
Proteins
Advanced Glycosylation End Products
Proteostasis Deficiencies
Manuscripts
Huntington Disease
Amyotrophic Lateral Sclerosis
Parkinson Disease
Electron Microscopy
Alzheimer Disease
Light
Antibodies

Keywords

  • Advanced glycation end-products
  • Exosome
  • Neurodegenerative diseases
  • Prion diseases
  • Prionoids
  • RAGEs
  • Synucleinopathies

ASJC Scopus subject areas

  • Cell Biology
  • Histology
  • Biophysics

Cite this

Histochemical approaches to assess cell-to-cell transmission of misfolded proteins in neurodegenerative diseases. / Natale, G.; Pompili, E.; Biagioni, F.; Paparelli, S.; Lenzi, P.; Fornai, F.

In: European journal of histochemistry : EJH, Vol. 57, No. 1, 2013, p. 31-35.

Research output: Contribution to journalArticle

@article{218440d70ad642b8941e2082c9370df9,
title = "Histochemical approaches to assess cell-to-cell transmission of misfolded proteins in neurodegenerative diseases",
abstract = "Formation, aggregation and transmission of abnormal proteins are common features in neurodegenerative disorders including Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, and Huntington's disease. The mechanisms underlying protein alterations in neurodegenerative diseases remain controversial. Novel findings highlighted altered protein clearing systems as common biochemical pathways which generate protein misfolding, which in turn causes protein aggregation and protein spreading. In fact, proteinaceous aggregates are prone to cell-tocell propagation. This is reminiscent of what happens in prion disorders, where the prion protein misfolds thus forming aggregates which spread to neighbouring cells. For this reason, the term prionoids is currently used to emphasize how several misfolded proteins are transmitted in neurodegenerative diseases following this prion-like pattern. Histochemical techniques including the use of specific antibodies covering both light and electron microscopy offer a powerful tool to describe these phenomena and investigate specific molecular steps. These include: prion like protein alterations; glycation of prion-like altered proteins to form advanced glycation end-products (AGEs); mechanisms of extracellular secretion; interaction of AGEs with specific receptors placed on neighbouring cells (RAGEs). The present manuscript comments on these phenomena aimed to provide a consistent scenario of the available histochemical approaches to dissect each specific step.",
keywords = "Advanced glycation end-products, Exosome, Neurodegenerative diseases, Prion diseases, Prionoids, RAGEs, Synucleinopathies",
author = "G. Natale and E. Pompili and F. Biagioni and S. Paparelli and P. Lenzi and F. Fornai",
year = "2013",
doi = "10.4081/ejh.2013.e5",
language = "English",
volume = "57",
pages = "31--35",
journal = "European Journal of Histochemistry",
issn = "1121-760X",
publisher = "PagePress",
number = "1",

}

TY - JOUR

T1 - Histochemical approaches to assess cell-to-cell transmission of misfolded proteins in neurodegenerative diseases

AU - Natale, G.

AU - Pompili, E.

AU - Biagioni, F.

AU - Paparelli, S.

AU - Lenzi, P.

AU - Fornai, F.

PY - 2013

Y1 - 2013

N2 - Formation, aggregation and transmission of abnormal proteins are common features in neurodegenerative disorders including Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, and Huntington's disease. The mechanisms underlying protein alterations in neurodegenerative diseases remain controversial. Novel findings highlighted altered protein clearing systems as common biochemical pathways which generate protein misfolding, which in turn causes protein aggregation and protein spreading. In fact, proteinaceous aggregates are prone to cell-tocell propagation. This is reminiscent of what happens in prion disorders, where the prion protein misfolds thus forming aggregates which spread to neighbouring cells. For this reason, the term prionoids is currently used to emphasize how several misfolded proteins are transmitted in neurodegenerative diseases following this prion-like pattern. Histochemical techniques including the use of specific antibodies covering both light and electron microscopy offer a powerful tool to describe these phenomena and investigate specific molecular steps. These include: prion like protein alterations; glycation of prion-like altered proteins to form advanced glycation end-products (AGEs); mechanisms of extracellular secretion; interaction of AGEs with specific receptors placed on neighbouring cells (RAGEs). The present manuscript comments on these phenomena aimed to provide a consistent scenario of the available histochemical approaches to dissect each specific step.

AB - Formation, aggregation and transmission of abnormal proteins are common features in neurodegenerative disorders including Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, and Huntington's disease. The mechanisms underlying protein alterations in neurodegenerative diseases remain controversial. Novel findings highlighted altered protein clearing systems as common biochemical pathways which generate protein misfolding, which in turn causes protein aggregation and protein spreading. In fact, proteinaceous aggregates are prone to cell-tocell propagation. This is reminiscent of what happens in prion disorders, where the prion protein misfolds thus forming aggregates which spread to neighbouring cells. For this reason, the term prionoids is currently used to emphasize how several misfolded proteins are transmitted in neurodegenerative diseases following this prion-like pattern. Histochemical techniques including the use of specific antibodies covering both light and electron microscopy offer a powerful tool to describe these phenomena and investigate specific molecular steps. These include: prion like protein alterations; glycation of prion-like altered proteins to form advanced glycation end-products (AGEs); mechanisms of extracellular secretion; interaction of AGEs with specific receptors placed on neighbouring cells (RAGEs). The present manuscript comments on these phenomena aimed to provide a consistent scenario of the available histochemical approaches to dissect each specific step.

KW - Advanced glycation end-products

KW - Exosome

KW - Neurodegenerative diseases

KW - Prion diseases

KW - Prionoids

KW - RAGEs

KW - Synucleinopathies

UR - http://www.scopus.com/inward/record.url?scp=84875014167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875014167&partnerID=8YFLogxK

U2 - 10.4081/ejh.2013.e5

DO - 10.4081/ejh.2013.e5

M3 - Article

C2 - 23549464

AN - SCOPUS:84875014167

VL - 57

SP - 31

EP - 35

JO - European Journal of Histochemistry

JF - European Journal of Histochemistry

SN - 1121-760X

IS - 1

ER -